Patent · US Active

Compounds for inflammation and immune-related uses

US8314134B2 · kind B2 · utility

1Cited by

23References

25Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Shoujun Chen · Bedford, US
Jun Jiang · Shanghai, CN
Hao Li · Brookline, US
David James · Cambridge, US
Dinesh U. Chimmanamada · Arlington, US
Christopher Borella · Bedford, US
Lijun Sun · Harvard, US
Yu Xie · Natick, US
Mats Holmqvist · Handen, SE
Jerome Mahiou · Lexington, US
Zhiqiang Xia · Acton, US

Key dates

Filing date	Mar 5, 2010
Grant date	Nov 20, 2012
Priority date	—
Expiry date	Jun 1, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.